arrow
P

Petros Bakakos

1
H指数:32
被引数:3,772

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

29-mRNA host response signatures for classification of bacterial infection, viral infection and disease progression in COVID-19 pneumonia: a post hoc analysis of the SAVE-MORE randomized clinical trial

29-mRNA宿主反应特征在COVID-19肺炎中区分细菌感染、病毒感染和疾病进展的分类:SAVE-MORE随机临床试验的事后分析

2025-06-300
OAAI
Impact of Biologics Initiation on Oral Corticosteroid Use in the International Severe Asthma Registry and the Optimum Patient Care Research Database: A Pooled Analysis of Real-World Data

生物制剂启动对口服糖皮质激素使用的影响:国际重症哮喘注册登记研究与国际患者护理研究数据库的真实世界数据合并分析

2025-04-260
OAAI
T2-low severe asthma clinical spectrum and impact: The Greek PHOLLOW cross-sectional study

T2-low重症哮喘临床谱及影响:希腊PHOLLOW横断面研究

2025-01-290
OAAI
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab: A post-hoc analysis of RELIght study

重度嗜酸性哮喘患者接受美泊利单抗治疗后的临床缓解:RELight研究的事后分析

2025-01-011
PRE
Effectiveness of Mepolizumab in patients with late-onset severe eosinophilic asthma and fixed obstruction, a 2-Year Follow-Up: The MESILICO study
2024-10-300
PRE
The REALISM Study: The Experience of Pulmonologists with Benralizumab in Greece
2024-10-300
PRE
Clinical remission in patients with severe eosinophilic asthma treated with mepolizumab:a post-hoc analysis of the 2-year RELIght study
2024-10-300
PRE
Oral corticosteroids and biologics use in the Greek Severe Asthma Registry (GSAR)
2024-10-300
PRE
Management of patients with pleural infection in Greece: initial results of the ongoing PRACTICE (PleuRAl InfeCTIon in GreeCE) study
2024-10-300
PRE